Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin plus rifampicin for MDR Acinetobacter baumannii infections
NCT01577862Phase 3Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Nov 2008
- Primary completion
- Aug 2011
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rifampicin in Acinetobacter baumannii infection, sponsored by University of Campania Luigi Vanvitelli. Started Nov 2008; status: completed.
02
Drugs
rifampicin
03
Conditions
Acinetobacter baumannii infection
Beyond the preview
Go deeper on NCT01577862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01577862.